2016
Patient stem cell (SC)-derived prostate cancer (PC) organoids (Org) to recreate clonal heterogeneity of PC foci and measure therapeutic response potential.
Ferrari A, DiPaola R, Bertino J, Kim I, Stein M, Sabaawy H, Bartucci M. Patient stem cell (SC)-derived prostate cancer (PC) organoids (Org) to recreate clonal heterogeneity of PC foci and measure therapeutic response potential. Journal Of Clinical Oncology 2016, 34: 252-252. DOI: 10.1200/jco.2016.34.2_suppl.252.Peer-Reviewed Original ResearchResidual tumor fociMesenchymal growth factorsRadical prostatectomy specimensClonal heterogeneityTumor initiating cellsProstate cancer organoidsMechanisms of resistanceMetastatic PCPC progressionTherapeutic alternativeTumor fociNormal epitheliumPatient stem cellsProstatectomy specimensMolecular alterationsPotential efficacyCancer organoidsSelf-renewal capacityInitiating cellsGrowth factorBiologic responseEarly passagesGrowth inhibitionStem cellsEpigenetic alterations
2013
Therapeutic Role of Bmi-1 Inhibitors in Eliminating Prostate Tumor Stem Cells
Kim I, Bertino J, Sabaawy H. Therapeutic Role of Bmi-1 Inhibitors in Eliminating Prostate Tumor Stem Cells. 2013 DOI: 10.21236/ada598365.Peer-Reviewed Original ResearchProstate tumor-initiating cellsTumor-initiating cellsBmi-1Stem cellsTreatment of zebrafishCancer cell senescenceMouse xenograftsZebrafish xenograft modelCell cycle arrestG1 cell cycle arrestCellular senescenceTranslational inhibitorBmi-1 expressionTumor stem cellsCell senescenceCycle arrestCurrent therapiesTherapeutic roleProstate cancerInvasion abilityTherapeutic strategiesXenograft modelCD44hi cellsTumor growthMetastatic potential